El caso de inversión para la hepatitis B y C en Sudáfrica: adaptación e innovación en el análisis de políticas para la ampliación del programa de enfermedades
Summary Even though WHO has approved global goals for hepatitis elimination, most countries have yet to establish programs for hepatitis B and C, which account for 320 million infections and over a million deaths annually. One reason for this slow response is the paucity of robust, compelling analyses showing that national HBV/HCV programs could have […]
Spanish 
English 
French 
Russian 
Arabic